MBBS, FACD, PhD, Director, Victorian Melanoma Service, Alfred Hospital, Vic; Adjunct Associate Professor, School of Public Health and Preventive Medicine, Monash University, Vic
As the COVID-19 pandemic has reduced face-to-face medical consultations, reduced diagnoses of thin melanomas and delayed presentations of thick melanomas were anticipated.
Clinical trials evaluating the impact of sentinel node biopsy, completion lymph node dissection and adjuvant medical therapies on patient outcomes have changed practice significantly.
Clinician/pathologist communication is important for accurate diagnosis of melanocytic skin tumours.
These findings will inform the development, dissemination and evaluation of education strategies to improve knowledge of sentinel lymph node biopsy and lead to better patient outcomes.